How to get in on the ground floor of AI’s most important “subsector”

[RiskHedge Roundup] It’s hands down the biggest moneymaking opportunity in AI. And the best part? Unlike other industries that have already seen a complete “AI transformation”… this opportunity is just starting. In other words… It’s a way to get in on the ground floor of the most important artificial intelligence trend on the planet! If you read Wednesday’s special interview with microcap expert Chris Wood, you know I’m talking about AI in drug discovery and development. In short: AI can analyze massive amounts of data and make predictions based on that data. As a result, it has begun to completely disrupt the “old way” of making drugs... which involved billions of wasted dollars... years of delays... and far more failures than successes. Today’s chart shows the global AI drug discovery market is projected to grow at a blistering 40.5% per year over the next seven years. By 2027, it will be a $3.9 billion industry… Source: Data Bridge Here’s Chris Wood: Make no mistake: This market is transforming before our eyes. In fact, analysts project that by 2024, 40% of global AI healthcare dollars will be spent on drug development! That’s a total disruption of the market. And it will be led by smaller, newer companies that were built from the ground up using this new business model. Chris’ top microcap to play disruption is a little-known company with a patented, breakthrough AI. Its tech has been validated in blind case studies with over 80% accuracy. Meanwhile, the company already has three drugs in development. (One of its drugs is for treating non-small cell lung cancer. And the company is currently in discussions with the FDA to launch a Phase 2 trial in the US as soon as this month.) It’s still in the early days for AI in drug development... so this small company is nowhere near the radar of most investors. But according to Chris, this company will save thousands of lives by bringing certain drugs to folks who need them much faster, and for much cheaper, than has ever been possible before its breakthrough technology. Once that happens, the stock should soar. Chris’ latest projections show 900%+ gains are possible within the next 2 years. If you’re interested in this opportunity, now’s your chance… [Go here to take advantage](. Chris Reilly Executive Editor, RiskHedge This email was sent to {EMAIL} as part of your subscription to RiskHedge Report. To opt-out, please visit the [email preferences page](. [READ IMPORTANT DISCLOSURES HERE.]( YOUR USE OF THESE MATERIALS IS SUBJECT TO THE TERMS OF THESE DISCLOSURES. Copyright © 2021 RiskHedge. All Rights Reserved RiskHedge | PO Box 1423 | Stowe, VT 05672